Combination therapy with glutaminase inhibitors and immuno-oncology agents

The invention relates to methods of treating cancer, myeloproliferative diseases, or immunological or neurological diseases with a combination of a glutaminase inhibitor and an immuno-oncology therapeutic agent, such as an inhibitor of arginase, CTLA-4, indoleamine 2,3-dioxygenase, and/or PD-1/PD-L1...

Full description

Saved in:
Bibliographic Details
Main Authors Bennett, Mark K, Bromley, Susan D, Parlati, Francesco, Molineaux, Susan M, Gross, Matthew I
Format Patent
LanguageEnglish
Published 09.03.2021
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

Abstract The invention relates to methods of treating cancer, myeloproliferative diseases, or immunological or neurological diseases with a combination of a glutaminase inhibitor and an immuno-oncology therapeutic agent, such as an inhibitor of arginase, CTLA-4, indoleamine 2,3-dioxygenase, and/or PD-1/PD-L1.
AbstractList The invention relates to methods of treating cancer, myeloproliferative diseases, or immunological or neurological diseases with a combination of a glutaminase inhibitor and an immuno-oncology therapeutic agent, such as an inhibitor of arginase, CTLA-4, indoleamine 2,3-dioxygenase, and/or PD-1/PD-L1.
Author Molineaux, Susan M
Bromley, Susan D
Gross, Matthew I
Parlati, Francesco
Bennett, Mark K
Author_xml – fullname: Bennett, Mark K
– fullname: Bromley, Susan D
– fullname: Parlati, Francesco
– fullname: Molineaux, Susan M
– fullname: Gross, Matthew I
BookMark eNqNyj0OgkAQQOEttPDvDuMBSEAptJVojK1akwHGZRJ2hrBDDLfXwgNYveJ7SzcTFVq4W6GhYkFjFbCWBuwneLO14LvRMHwpErC0XLHpEAGlAQ5hFE1Uau3UT4CexOLazV_YRdr8unLby_lRXBPqtaTYY01CVj7vWXrM0yw_nHb7f54Puko32w
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US10940148B2
GroupedDBID EVB
ID FETCH-epo_espacenet_US10940148B23
IEDL.DBID EVB
IngestDate Fri Jul 19 15:07:30 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US10940148B23
Notes Application Number: US201916265529
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210309&DB=EPODOC&CC=US&NR=10940148B2
ParticipantIDs epo_espacenet_US10940148B2
PublicationCentury 2000
PublicationDate 20210309
PublicationDateYYYYMMDD 2021-03-09
PublicationDate_xml – month: 03
  year: 2021
  text: 20210309
  day: 09
PublicationDecade 2020
PublicationYear 2021
RelatedCompanies Calithera Biosciences, Inc
RelatedCompanies_xml – name: Calithera Biosciences, Inc
Score 3.3171904
Snippet The invention relates to methods of treating cancer, myeloproliferative diseases, or immunological or neurological diseases with a combination of a glutaminase...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title Combination therapy with glutaminase inhibitors and immuno-oncology agents
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210309&DB=EPODOC&locale=&CC=US&NR=10940148B2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFfWmVdH6YAXJLbhJkyY5BCEvSqEPbCO9lc2jGg-bYiLSf-_smlovelt2YRmG_WZ2Z-ebAbhPKWUspY66ojJapYtPQo2ptmMkmp1nKyp7Ro7G_UFsDBfmogVvWy6MrBP6KYsjIqJSxHst7fV6F8QKZG5l9ZAUOFU-RnM3UJrXsS6aZjlK4LnhdBJMfMX33XimjJ_wrusYInjmobnew2u0JdAQPnuClbL-7VKiY9if4m68PoFWzjtw6G87r3XgYNR8eOOwwV51CkOELj5jpXDkmza1ISKMSl7w9DCR0lLlpOCvRVKIFjqE8YwUgv5RqiWXxak3hAkmVXUGd1E49wcqCrX80cAynu3k751Dm5c8vwBCcxudi8VErWHDoQljmrmyMr2Xmno_o-YldP_ep_vf4hUcCW3KZCvnGtr1-0d-g963Tm6l2r4A02iKDw
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFOebTkXnVwTpWzHt2m19KMLalTr3hVtlbyX9mNaHdNiK7L_3Ejfni76FBMJx5HeXXO53B3AbU8pYTC11QWW0ShefhBpTO5YRaZ00WVDZM3I4avmB0Z-b8wq8bbgwsk7opyyOiIiKEe-ltNfLbRDLlbmVxV2U4VR-781sV1m_jnXRNMtS3K7dm4zdsaM4jh1MldET3nUtQwTPumiud_CK3RZo6D13BStl-duleAewO8HdeHkIlZTXoeZsOq_VYW-4_vDG4Rp7xRH0Ebr4jJXCkW_a1IqIMCp5wdPDREpLkZKMv2ZRJlroEMYTkgn6R67mXBanXhEmmFTFMdx4vZnjqyhU-KOBMJhu5W-eQJXnPD0FQtMOOpc2E7WGDYtGjGnmop3ozdjUWwk1z6Dx9z6N_xavoebPhoNw8DB6PId9oVmZeGVdQLV8_0gv0ROX0ZVU4Rd49o0C
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Combination+therapy+with+glutaminase+inhibitors+and+immuno-oncology+agents&rft.inventor=Bennett%2C+Mark+K&rft.inventor=Bromley%2C+Susan+D&rft.inventor=Parlati%2C+Francesco&rft.inventor=Molineaux%2C+Susan+M&rft.inventor=Gross%2C+Matthew+I&rft.date=2021-03-09&rft.externalDBID=B2&rft.externalDocID=US10940148B2